Highly Emetogenic Chemotherapy | List of Frontiers open access articles

Clinical Trial

Published on 16 Jan 2018

Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials

in Gastrointestinal and Hepatic Pharmacology

Toshiyuki Harada
Toraji Amano
Tomoo Ikari
Kei Takamura
Takahiro Ogi
Toshiaki Fujikane
Yuka Fujita
Kageaki Taima
Hisashi Tanaka
Takaaki Sasaki

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00972

5,776 views
18 citations

Original Research

Published on 29 Sep 2025

Efficacy of single low-dose dexamethasone with NEPA for the 168 h prevention of highly or moderately emetogenic chemotherapy

in Pharmacology of Anti-Cancer Drugs

Yuting He
Fanzhuoran Lou
XinTian Huang
Yiqin Zhang
Qunbo Lin
Weijuan Tan
Quan Chen
Xiurong Ren
Huibo Shi
Li Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1622789

1,919 views

Systematic Review

Published on 05 Jan 2026

Acupuncture for nausea and vomiting induced by highly emetogenic chemotherapy: a systematic review and meta-analysis

in Experimental Therapeutics

Run Lin
Zining Guo
Jiewen Zhang
Liying Wang
Lu Zhang
Xiaorong Tang
Wenhao Liu
Shaoyang Cui
Nenggui Xu

Frontiers in Neurology

doi 10.3389/fneur.2025.1692411

1,340 views

Original Research

Published on 20 Sep 2023

Chemotherapy induced nausea and vomiting may cause anxiety and depression in the family caregivers of patients with cancer

in Public Mental Health

Xiaozhen Luo
Lili Yang
Jing Chen
Jing Zhang
Quanqing Zhao
Jiang Zhu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1221262

4,116 views
8 citations

Systematic Review

Published on 30 Sep 2021

The Balance Between the Effectiveness and Safety for Chemotherapy-Induced Nausea and Vomiting of Different Doses of Olanzapine (10 mg Versus 5 mg): A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Dong-Yang Wang
Yi Chen
You Zhang
Ying-Qiang Shen

Frontiers in Oncology

doi 10.3389/fonc.2021.705866

7,593 views
10 citations

Systematic Review

Published on 24 Jan 2022

Efficacy and Safety of Thalidomide As a Pre-Medication of Chemotherapy-Induced Nausea and Vomiting (CINV) Following Highly Emetogenic Chemotherapy (HEC): A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Jiyi Xie
Cong Zhang
Shijun Li
Rong Dai
Mitchell A. Sullivan
Bin Deng
Qiling Xu
Jinglin Wang
Chen Shi
Yu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.818839

4,333 views
5 citations

Articles

Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials

Efficacy of single low-dose dexamethasone with NEPA for the 168 h prevention of highly or moderately emetogenic chemotherapy

Acupuncture for nausea and vomiting induced by highly emetogenic chemotherapy: a systematic review and meta-analysis

Chemotherapy induced nausea and vomiting may cause anxiety and depression in the family caregivers of patients with cancer

The Balance Between the Effectiveness and Safety for Chemotherapy-Induced Nausea and Vomiting of Different Doses of Olanzapine (10 mg Versus 5 mg): A Systematic Review and Meta-Analysis

Efficacy and Safety of Thalidomide As a Pre-Medication of Chemotherapy-Induced Nausea and Vomiting (CINV) Following Highly Emetogenic Chemotherapy (HEC): A Systematic Review and Meta-Analysis